Search results
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1...
Zacks· 7 days agoWhile this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock
Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks via Yahoo Finance· 2 days agoThe biotechnology company's stock has climbed by 0.69% in the past month, exceeding the Medical...
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 3 days agoLexicon (LXRX) delivered earnings and revenue surprises of -11.11% and 3.09%, respectively, for the...
Q3 2025 EPS Estimates for Teva Pharmaceutical Industries Limited Boosted by Analyst (NYSE:TEVA)
ETF DAILY NEWS· 2 days agoDepartment now forecasts that the company will earn $0.62 per share for the quarter, up from their previous forecast of $0.61. The consensus estimate for Teva Pharmaceutical ...
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
Zacks· 5 days agoThe earnings report, which is expected to be released on May 8, 2024, might help the stock move higher if these key numbers are better than expectations. This specialty < ...
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
Benzinga via Yahoo Finance· 6 days agoOn Monday, Japanese pharma company ONO Pharmaceutical agreed to acquire Deciphera Pharmaceuticals...
Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should...
Zacks via Yahoo Finance· 4 days agoZacks.com users have recently been watching Recursion Pharmaceuticals (RXRX) quite a bit. Thus, it...
Ready to Invest in Artificial Intelligence in 2024? 2 Stocks to Buy and Hold for Decades (Hint:...
Motley Fool via Yahoo Finance· 2 days agoFor example, it can streamline processes or help a pharmaceutical company develop drugs more...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 6 days agoBut others are coming and could rock Eli Lilly stock. Viking Therapeutics soared after its...
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
Pharmaceutical Technology via Yahoo Finance· 6 days agoFollowing the announcement of acquisition, Deciphera’s stock has jumped 71.9%. Waltham,...